s6y
Company name or ticker
Search
Sienna Biopharmaceuticals, Inc.
4
Harris Todd: Statement of changes in beneficial ownership of securities
Filed
Monday, April 9, 2018
Period
Apr 5, 2018
Accession number
0001140361-18-017877
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header